1. Home
  2. COLL vs SCL Comparison

COLL vs SCL Comparison

Compare COLL & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • SCL
  • Stock Information
  • Founded
  • COLL 2002
  • SCL 1932
  • Country
  • COLL United States
  • SCL United States
  • Employees
  • COLL 357
  • SCL N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • SCL Package Goods/Cosmetics
  • Sector
  • COLL Health Care
  • SCL Consumer Discretionary
  • Exchange
  • COLL Nasdaq
  • SCL Nasdaq
  • Market Cap
  • COLL 1.1B
  • SCL 1.1B
  • IPO Year
  • COLL 2015
  • SCL N/A
  • Fundamental
  • Price
  • COLL $34.62
  • SCL $44.69
  • Analyst Decision
  • COLL Strong Buy
  • SCL
  • Analyst Count
  • COLL 4
  • SCL 0
  • Target Price
  • COLL $44.25
  • SCL N/A
  • AVG Volume (30 Days)
  • COLL 319.8K
  • SCL 156.6K
  • Earning Date
  • COLL 11-06-2025
  • SCL 10-29-2025
  • Dividend Yield
  • COLL N/A
  • SCL 3.49%
  • EPS Growth
  • COLL N/A
  • SCL N/A
  • EPS
  • COLL 1.06
  • SCL 1.98
  • Revenue
  • COLL $707,007,000.00
  • SCL $2,303,837,000.00
  • Revenue This Year
  • COLL $21.29
  • SCL $9.25
  • Revenue Next Year
  • COLL $3.36
  • SCL $7.93
  • P/E Ratio
  • COLL $32.88
  • SCL $22.33
  • Revenue Growth
  • COLL 22.61
  • SCL 5.35
  • 52 Week Low
  • COLL $23.23
  • SCL $43.15
  • 52 Week High
  • COLL $39.95
  • SCL $82.08
  • Technical
  • Relative Strength Index (RSI)
  • COLL 49.72
  • SCL 37.22
  • Support Level
  • COLL $34.46
  • SCL $43.15
  • Resistance Level
  • COLL $35.90
  • SCL $45.92
  • Average True Range (ATR)
  • COLL 0.97
  • SCL 1.07
  • MACD
  • COLL 0.19
  • SCL -0.16
  • Stochastic Oscillator
  • COLL 69.18
  • SCL 29.82

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: